Literature DB >> 21585432

Expression of the helicase-like transcription factor and its variants during carcinogenesis of the uterine cervix: implications for tumour progression.

Aurélie Capouillez, Jean-Christophe Noël, Mohammad Arafa, Vanessa Arcolia, Mustapha Mouallif, Samuel Guenin, Philippe Delvenne, Alexandra Belayew, Sven Saussez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21585432     DOI： 10.1111/j.1365-2559.2011.03843.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  7 in total

Review 1.  The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor?

Authors:  Ludovic Dhont; Céline Mascaux; Alexandra Belayew
Journal:  Cell Mol Life Sci       Date:  2016-01       Impact factor: 9.261

2.  Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.

Authors:  Chi Keung Cheng; Natalie P H Chan; Thomas S K Wan; Lai Ying Lam; Coty H Y Cheung; Terry H Y Wong; Rosalina K L Ip; Raymond S M Wong; Margaret H L Ng
Journal:  Haematologica       Date:  2016-01-22       Impact factor: 9.941

3.  Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC).

Authors:  Ludovic Dhont; Melania Pintilie; Ethan Kaufman; Roya Navab; Shirley Tam; Arsène Burny; Frances Shepherd; Alexandra Belayew; Ming-Sound Tsao; Céline Mascaux
Journal:  BMC Cancer       Date:  2018-04-16       Impact factor: 4.430

4.  Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers.

Authors:  Vanessa Arcolia; Paula Paci; Ludovic Dhont; Gilbert Chantrain; Nicolas Sirtaine; Christine Decaestecker; Myriam Remmelink; Alexandra Belayew; Sven Saussez
Journal:  BMC Cancer       Date:  2014-07-08       Impact factor: 4.430

5.  Differential genomics and transcriptomics between tyrosine kinase inhibitor-sensitive and -resistant BCR-ABL-dependent chronic myeloid leukemia.

Authors:  Neetu Singh; Anil Kumar Tripathi; Dinesh Kumar Sahu; Archana Mishra; Margaret Linan; Bianca Argente; Julia Varkey; Niranjan Parida; Rebecca Chowdhry; Hari Shyam; Nawazish Alam; Shivani Dixit; Pratap Shankar; Abhishek Mishra; Avinash Agarwal; Chris Yoo; Madan Lal Brahma Bhatt; Ravi Kant
Journal:  Oncotarget       Date:  2018-07-13

6.  Helicase-Like Transcription Factor HLTF and E3 Ubiquitin Ligase SHPRH Confer DNA Damage Tolerance through Direct Interactions with Proliferating Cell Nuclear Antigen (PCNA).

Authors:  Mareike Seelinger; Marit Otterlei
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

7.  The Human RAD5 Homologs, HLTF and SHPRH, Have Separate Functions in DNA Damage Tolerance Dependent on The DNA Lesion Type.

Authors:  Mareike Seelinger; Caroline Krogh Søgaard; Marit Otterlei
Journal:  Biomolecules       Date:  2020-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.